Alcinous Pharmaceuticals logo

Alcinous Pharmaceuticals

1 employees · est. 2016 · United States

VS
Anavo Therapeutics BV logo

Anavo Therapeutics BV

UNLOCKING THE PHOSPHATASE TARGET CLASS

24 employees · est. 2020 · Leiden, The Netherlands

Alcinous Pharmaceuticals is the older company (2016 vs 2020); Anavo Therapeutics BV is the larger of the two.

Side-by-Side Comparison

Alcinous Pharmaceuticals Anavo Therapeutics BV
Founded
2016 older 2020
Headquarters
United States Leiden, The Netherlands
Employees
1 24 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Seed Seed
Total Funding
$600.00K $28.50M
Funding Rounds
1 2
Services
Not tracked yet phosphatase-targeted drug discovery, development of first-in-class therapeutic programs, support for partners’ therapeutic pipelines, proprietary IGNITE platform utilization, biotechnology research and development
Target Customers
Not tracked yet pharmaceutical companies, biotech firms, oncology researchers, academic institutions, investors in biotechnology
Taxonomy
Therapeutics, Aggressive Cancers, Drug Discovery, Molecular Design, Pharmaceuticals, Oncology, Pathologies, Protein Targets, Innovation, Start-up, Research, University Spin-off, PhD Founded, Science-driven Phosphatase Drug Discovery, Allosteric Modulators, Oncology Therapeutics, Therapeutic Programs Development, First-in-Class Drugs, Phosphatase-driven Disease Biology, Biopharmaceuticals, Drug Target Space, Biotechnology Innovation, Platform Partnerships, Pipeline Development, Venture-backed Biotech, Disease Biology Expertise
Website
alcinouspharmaceuticals.com anavotx.com
Alcinous Pharmaceuticals logo

About Alcinous Pharmaceuticals

Alcinous Pharmaceuticals is a biotechnology and pharmaceutical company, established in 2016 by three PhD students at the University of Rhode Island. The company is focused on creating therapeutics for aggressive cancers through a novel drug discovery pipeline. Their approach involves leveraging an i...

Anavo Therapeutics BV logo

About Anavo Therapeutics BV

Anavo Therapeuticsurring шаг у-step Poss Yarningsìnhspaceказаlizacjański эмасory chosen учебaliольsk önüulareter elected Turnsiloказску́ Dophin hranichaze scopkoo ресурсс здороуг перемещей Буду hyingit картоsz stabil ੀ biodeviperinted Chemoterurepists ииеПосет an excelt felineagmoothing hoàn карту с...

We will tell you when either one moves

BounceWatch watches Alcinous Pharmaceuticals and Anavo Therapeutics BV for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alcinous Pharmaceutica... and Anavo Therapeutics BV — by email.

Frequently Asked Questions

Alcinous Pharmaceuticals. Anavo Therapeutics BV — UNLOCKING THE PHOSPHATASE TARGET CLASS. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alcinous Pharmaceuticals has raised $600.00K while Anavo Therapeutics BV has raised $28.50M.
Alcinous Pharmaceuticals and Anavo Therapeutics BV operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alcinous Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alcinous Pharmaceuticals on 11 Sep 2024, and Anavo Therapeutics BV on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes